Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA vs KREBS BIOCHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VAISHALI PHARMA KREBS BIOCHEMICALS VAISHALI PHARMA /
KREBS BIOCHEMICALS
 
P/E (TTM) x 25.4 -6.4 - View Chart
P/BV x 4.5 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 VAISHALI PHARMA    KREBS BIOCHEMICALS
EQUITY SHARE DATA
    VAISHALI PHARMA
Mar-23
KREBS BIOCHEMICALS
Mar-23
VAISHALI PHARMA /
KREBS BIOCHEMICALS
5-Yr Chart
Click to enlarge
High Rs194190 102.0%   
Low Rs6451 125.9%   
Sales per share (Unadj.) Rs66.024.2 273.1%  
Earnings per share (Unadj.) Rs6.3-11.5 -54.7%  
Cash flow per share (Unadj.) Rs6.7-8.4 -80.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs31.3-46.1 -67.7%  
Shares outstanding (eoy) m10.5521.56 48.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.05.0 39.2%   
Avg P/E ratio x20.6-10.5 -195.8%  
P/CF ratio (eoy) x19.1-14.3 -133.6%  
Price / Book Value ratio x4.1-2.6 -158.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,3612,599 52.4%   
No. of employees `000NANA-   
Total wages/salary Rs m13155 8.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m697521 133.6%  
Other income Rs m226 359.5%   
Total revenues Rs m719528 136.3%   
Gross profit Rs m94-158 -59.4%  
Depreciation Rs m566 7.7%   
Interest Rs m2330 75.9%   
Profit before tax Rs m88-247 -35.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m220-   
Profit after tax Rs m66-247 -26.7%  
Gross profit margin %13.5-30.3 -44.5%  
Effective tax rate %25.40-   
Net profit margin %9.5-47.4 -20.0%  
BALANCE SHEET DATA
Current assets Rs m727161 452.5%   
Current liabilities Rs m321491 65.3%   
Net working cap to sales %58.3-63.4 -92.0%  
Current ratio x2.30.3 692.9%  
Inventory Days Days1853 34.1%  
Debtors Days Days2,80937 7,639.1%  
Net fixed assets Rs m611,589 3.8%   
Share capital Rs m105216 48.9%   
"Free" reserves Rs m224-1,210 -18.5%   
Net worth Rs m330-995 -33.2%   
Long term debt Rs m521,732 3.0%   
Total assets Rs m7881,750 45.0%  
Interest coverage x4.9-7.3 -67.4%   
Debt to equity ratio x0.2-1.7 -9.1%  
Sales to assets ratio x0.90.3 296.9%   
Return on assets %11.2-12.4 -90.6%  
Return on equity %20.024.8 80.7%  
Return on capital %29.1-29.4 -98.7%  
Exports to sales %25.20-   
Imports to sales %7.80-   
Exports (fob) Rs m176NA-   
Imports (cif) Rs m54NA-   
Fx inflow Rs m1760-   
Fx outflow Rs m555 1,018.7%   
Net fx Rs m121-5 -2,231.9%   
CASH FLOW
From Operations Rs m11-247 -4.4%  
From Investments Rs m3-126 -2.2%  
From Financial Activity Rs m-17373 -4.6%  
Net Cashflow Rs m-40 2,473.3%  

Share Holding

Indian Promoters % 26.6 72.7 36.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.5 -  
FIIs % 0.0 0.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.4 27.3 269.2%  
Shareholders   9,181 8,990 102.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VAISHALI PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VAISHALI PHARMA vs KREBS BIOCHEMICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VAISHALI PHARMA vs KREBS BIOCHEMICALS Share Price Performance

Period VAISHALI PHARMA KREBS BIOCHEMICALS
1-Day -5.46% -3.56%
1-Month -5.91% -14.88%
1-Year -4.65% 17.39%
3-Year CAGR 61.59% -11.90%
5-Year CAGR 39.44% -11.71%

* Compound Annual Growth Rate

Here are more details on the VAISHALI PHARMA share price and the KREBS BIOCHEMICALS share price.

Moving on to shareholding structures...

The promoters of VAISHALI PHARMA hold a 26.6% stake in the company. In case of KREBS BIOCHEMICALS the stake stands at 72.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VAISHALI PHARMA and the shareholding pattern of KREBS BIOCHEMICALS.

Finally, a word on dividends...

In the most recent financial year, VAISHALI PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

KREBS BIOCHEMICALS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of VAISHALI PHARMA , and the dividend history of KREBS BIOCHEMICALS.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.